ArticleNeuro-oncology advances

Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria.

Sara Faye Borenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.